1538285200 FARMACIA CALDAS

Community/Retail Pharmacy

Active

Basic Information

Organization Name
FARMACIA CALDAS
Enumeration Date
March 22, 2007
Last Update
August 22, 2020
Authorized Official
ARIEL CALDAS
OWNER
Phone: (787) 851-2079

Practice Location

Address
CARR. 101 KM. 18.1
BOQUERON, PR 00622
Phone
(787) 851-2079
Fax
(787) 255-3115

Mailing Address

Address
PO BOX 1146
BOQUERON, PR 006221146
Phone
(787) 851-2079
Fax
(787) 255-3115

Specialties & Taxonomies

Specialty Code Classification License State Primary
Community/Retail Pharmacy
Community/Retail Pharmacy
3336C0003X Pharmacy 09F1799 PR Primary

Frequently Asked Questions

What is FARMACIA CALDAS's NPI number?
FARMACIA CALDAS's NPI number is 1538285200.
Which doctor has NPI number 1538285200?
The doctor with NPI number 1538285200 is FARMACIA CALDAS.
What is FARMACIA CALDAS's practice address?
FARMACIA CALDAS's practice address is CARR. 101 KM. 18.1, BOQUERON, PR, 00622.
Which doctor practices at CARR. 101 KM. 18.1, BOQUERON, PR, 00622?
FARMACIA CALDAS practices at CARR. 101 KM. 18.1, BOQUERON, PR, 00622.
What is FARMACIA CALDAS's mailing address?
FARMACIA CALDAS's mailing address is PO BOX 1146, BOQUERON, PR, 006221146.
What is FARMACIA CALDAS's phone number?
FARMACIA CALDAS's phone number is (787) 851-2079.
Who is (787) 851-2079?
(787) 851-2079 is the phone number for FARMACIA CALDAS.
What is FARMACIA CALDAS's specialty?
FARMACIA CALDAS's specialty is Community/Retail Pharmacy.
What type of doctor is FARMACIA CALDAS?
FARMACIA CALDAS is a Community/Retail Pharmacy.
Is FARMACIA CALDAS a Community/Retail Pharmacy?
Yes, FARMACIA CALDAS is a Community/Retail Pharmacy.
Is FARMACIA CALDAS still practicing?
Yes, FARMACIA CALDAS is currently practicing.
Is FARMACIA CALDAS accepting new patients?
FARMACIA CALDAS may be accepting new patients. Please call their office at (787) 851-2079 to inquire about availability.
Is NPI 1538285200 still active?
Yes, NPI 1538285200 is currently active.
Where does FARMACIA CALDAS practice?
FARMACIA CALDAS practices in BOQUERON, PR.